Merck KGaA India plant faces partial work stoppage

Merck kgaa
Workers at a German Merck plant in India have gone on strike.

A Merck KGaA plant in Goa, India, has run into labor issues over wages and is now having to take steps to avoid product shortages.

The German drugmaker notified the Bombay Stock Exchange on Wednesday that “a section of the workforce” at the facility had stopped work while in negotiations with management over issues including pay. The company said it is trying to convince the strikers to return to work and resume negotiations.

Because the company has implemented its “business continuity plans,” it said it didn’t expect any impact on the availability of its products or on its finances.

Whitepaper

Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.

Strikes in India, while not frequent, occasionally arise. GlaxoSmithKline halted production last year at a consumer health plant in India that makes Horlicks nutritional drink products after workers there unexpectedly went on strike.

In 2014, Pfizer acknowledged it temporarily locked employees out of a plant in Thane, India, after workers reportedly tried to stop production and threatened managers.

Suggested Articles

Three Samsung execs face up to two years in jail for their roles in destroying data and documents at under-fire affiliate Samsung BioLogics.

The FDA has slapped a U.S. drug repackager, saying in a warning letter that its storage processes and equipment cleaning are not up to expectations.

Higher operating costs were behind a 17% slide in pretax profits last year at Allergan’s Mayo, Ireland, facility that produces Botox.